medigraphic.com
ISSN 1405-8871 (Print)

2018, Number 4

<< Back Next >>

Aten Fam 2018; 25 (4)

Gastric Cancer (Stomach Cancer)

Palmero PJ, Tron GMS, Tovar TS

Language: Spanish
References: 33
Page: 169-175
PDF size: 133.72 Kb.


ABSTRACT

Gastric cancer is one of the most common types of cancer in the world. It occupies the fifth place of malignant neoplasms. There is a decline in incidence and mortality due to the discovery of risk factors such as the presence of Helicobacter pylori or dietary associations, for example, excessive consumption of salt, processed meat, alcoholic beverages, among others. Most patients have an initial asymptomatic disease and show symptoms when they are in advanced stages. At present, the average diagnosis is about 69 years of age, the knowledge of adequate diagnosis and staging can be the difference between a survival of 66% to 5%. The screening method chosen is endoscopy, while the ideal treatment depends on the type of cancer and its staging. This may vary between resection, gastrectomy, chemotherapy, radiation therapy, or palliative medicine. A search in the databases of Pubmed, Cochrane, ebsco and Up to date was made, using bibliography in English language from the year 2012 onwards. The searched terms used were: etiology, risk factors, stomach cancer, epidemiology, treatment. We found a total of 306 articles. The selection criteria were: original articles, articles of no more than six years old, and articles updated in the treatment, epidemiology and staging, which had a relevant contribution to this research. After submitting these texts to the selection criteria, 33 articles were obtained.


REFERENCES

  1. Morgan D. Early gastric cancer: epidemiology, clinical manifestations, diagnosis and staging. Uptodate [Internet] [Citado 2018 Julio 24]. Disponible en: https://www.uptodate.com/ contents/early-gastric-cancer-epidemiologyclinical- manifestations-diagnosis-and-staging

  2. Long S, Xiao-Qin W, Su-Fang W, Shuai W, Min M, Yan Z, et al. Dietary Patterns and Stomach Cancer: A Meta- Analysis. Nutrition and Cancer. 2013;65(8),1105-15.

  3. Pierce L. Gastric cancer review. J Carcinog. 2014;13(1):13-14.

  4. Zhao G, Wu M, Wang X, Du Z, Zhang G. Effect of fabp-5 gene silencing on the proliferation, apoptosis and invasion of human gastric sgc-7901 cancer cells. Oncology Letters. 2017;14(4):772-778.

  5. Globocan. Prevalencia y mortalidad de cánceres por país y región [Internet]. [Citado 2018 julio 2012]. Disponible en: http://globocan.iarc.fr/ Default.aspx

  6. Putthacachote N, Promthet S, Hurst C, Suwanrungruang K, Chopjitt P, Wiangnon S, et al. The XRCC 1 DNA repair gene modifies the environmental risk of stomach cancer: a hospitalbased matched case-control study. BMC cancer. 2017;17(1):680.

  7. Morgan D. Early gastric cancer: epidemiology, clinical manifestations, diagnosis and staging. Uptodate [Internet]. [Citado 2018 Julio 24]. Disponible en: https://www.uptodate.com/contents/ early-gastric-cancer-epidemiology-clinical-manifestations- diagnosis-and-staging

  8. Chan A, Wong B. Epidemiology of gastric cancer. Uptodate [Internet]. [Citado 2018 Junio 4]. Disponible en: https://link.springer.com/ chapter/10.1007/978-3-319-15826-6_2

  9. Fock K. The epidemiology and prevention of gastric cancer. Alimentary Pharmacology & Therapeutics. 2014; 40(3):250-260.

  10. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Epidemiology of gastric cancer. In Gastric Cancer. 2017; 15(12):1833-43.

  11. Mansfield P. Clinical features, diagnosis, and staging of gastric cancer. Uptodate [Internet]. [Citado 2018 Junio 4]. Disponible en: https:// www.uptodate.com/contents/clinical-featuresdiagnosis- and-staging-of-gastric-cancer

  12. Guggenheim DE, Shah MA. Gastric Cancer Epidemiology and Risk Factors. Journal of Surgical Oncology. 2013;107(3):230-236.

  13. Holscher AH, Monig SP. Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction. [Internet]. [Citado 2018 Junio 11]. Disponible en: https://link.springer.com/chapter/ 10.1007%2F978-3-540-70579-6_2

  14. Goldberg R. Pathology and molecular pathogenesis of gastric cancer. Uptodate [Internet]. [Citado 2018 Junio 11]. Disponible en: https://www.uptodate. com/contents/pathology-and-molecularpathogenesis- of-gastric-cancer

  15. National Cancer Institute. Tobacco. NIH [Internet]. [citado 2018 Junio 19]. Disponible en: https://www.cancer.gov/news-events/cancercurrents- blog/2017/tobacco-global-economicburden

  16. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiology and Prevention Biomarkers. 2014;23(5):700-713.

  17. Singh S, Varayil JE, Devanna S, Murad MH, Iyer PG. Physical activity is associated with reduced risk of gastric cancer: a systematic review and meta-analysis. Cancer Prev Res. 2014;7(1):12-22.

  18. Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, et al. Stomach cancer risk after treatment for hodgkin lymphoma. J Clin Oncol. 2013;31(27):3369.

  19. Lim J, Kim N, Lee H, Choe G, Jo S, Chon, et al. Correlation between endoscopic and histological diagnoses of gastric intestinal metaplasia. Gut Liver. 2013;7(1):41-50.

  20. Choi KS, Jun JK, Suh M, Park B, Noh DK, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br. J. Cancer. 2015;112(3):608-612.

  21. Giroux V, Rustgi A. Metaplasia: Tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat. Rev. Cancer. 2017;17(10):594- 604.

  22. Fuchs C, Tomasek J, Yong C, Dumitru F, Passalacqua R, Goswami C, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (regard): an international, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet. 2014;383(9911):31-39.

  23. Nagini S. Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4(7):156-169.

  24. Kodera Y, Fujitani K, Fukushima N, Ito S, Muro K, Ohashi N, et al. Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer. 2014;17(2):206-212.

  25. Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010. Gastric Cancer. 2011;14(2):113-123.

  26. Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, et al. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31(7):868-875.

  27. Qiu M, Cai M, Zhang D, Wang Z, Wang D, Li Y, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. Journal of Translational Medicine. 2013;11(1):58.

  28. Sakitani K, Hirat, Y, Watab, H, Yamada A, Sugimoto T, Yamaji Y, et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. Journal of gastroenterology and hepatology. 2011;26(10):1570-75.

  29. Choi Y, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016;31(6):1042-53.

  30. Le Roux CW, Ghatei MA, Gibbs JSR, Bloom SR. The putative satiety hormone pyy is raised in cardiac cachexia associated with primary pulmonary hypertension. Heart. 2005;91(2):241-242.

  31. Shichijo S, Hirata Y, Sakitani K, Yamamoto S, Serizawa T, Niikura R, et al. Distribution of intestinal metaplasia as a predictor of gastric cancer development. Journal of gastroenterology and hepatology. 2015;30(8):1260-64.

  32. Massarrat S, Haj-Sheykholeslami A. Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention. Archives of Iranian Medicine. 2016;19(2):137.

  33. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric Cancer. Lancet. 2016;388(10060):2654-64.




2020     |     www.medigraphic.com